318 related articles for article (PubMed ID: 27876447)
1. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
Tay LM; Xu C
Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
[No Abstract] [Full Text] [Related]
2. Nano-lipospheres as acoustically active ultrasound contrast agents: evolving tumor imaging and therapy technique.
Andrews LE; Chan MH; Liu RS
Nanotechnology; 2019 May; 30(18):182001. PubMed ID: 30645984
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
4. Colloids, nanoparticles, and materials for imaging, delivery, ablation, and theranostics by focused ultrasound (FUS).
Yildirim A; Blum NT; Goodwin AP
Theranostics; 2019; 9(9):2572-2594. PubMed ID: 31131054
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
Zhou LQ; Li P; Cui XW; Dietrich CF
Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
[TBL] [Abstract][Full Text] [Related]
6. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
7. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
8. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
[TBL] [Abstract][Full Text] [Related]
9. Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors.
Fu JW; Lin YS; Gan SL; Li YR; Wang Y; Feng ST; Li H; Zhou GF
Contrast Media Mol Imaging; 2019; 2019():3145647. PubMed ID: 31360144
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
11. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
12. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
13. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
Schutt EG; Klein DH; Mattrey RM; Riess JG
Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
Mosayebi J; Kiyasatfar M; Laurent S
Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
[TBL] [Abstract][Full Text] [Related]
17. Polymer-Based Materials in Cancer Treatment: From Therapeutic Carrier and Ultrasound Contrast Agent to Theranostic Applications.
Methachan B; Thanapprapasr K
Ultrasound Med Biol; 2017 Jan; 43(1):69-82. PubMed ID: 27751594
[TBL] [Abstract][Full Text] [Related]
18. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Patra CR
Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
[No Abstract] [Full Text] [Related]
19. Exploring New Applications of Lysozyme-Shelled Microbubbles.
Lee L; Cavalieri F; Ashokkumar M
Langmuir; 2019 Aug; 35(31):9997-10006. PubMed ID: 31088060
[TBL] [Abstract][Full Text] [Related]
20. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
